CEO sold ~$96K of ADMA shares in the open market

Past results only. Not a forecast.

Record ID

0001140361-25-042997

Filed / recorded

Nov 22, 2025, 2:00 AM UTC

Added to OQRO

Oct 6, 2026, 9:54 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ADMA BIOLOGICS, INC.

Issuer CIK

1368514

Ticker

ADMA

Reporting person

Adam S Grossman

Relationship

Director, Officer

Officer title

President and CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 19, 2025

Transaction code

S

Shares / units

6,000

Price per share

$16.00

Acquired / disposed

Disposed (D)

Shares owned after

2,013,850

Ownership form

Direct

Amendment

No

1. Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer.
2. The price reported in Column 4 is the price at which the shares were sold.
3. Includes, as of the transaction date, (i) 252,022 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 418,296 unvested RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
4. (continued from footnote 3) (iii) 286,848 unvested RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
5. (continued from footnote 4) (iv) 75,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (v) 981,684 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.